1. World Health Organization (2011 c). mhGAP Intervention Guide for mental, neurological and substance use disorders in non-specialized health settings. WHO: Geneva. Retrieved 5 June 2012 from http://whqlibdoc.who.int/publications/2010/9789241548069_eng.pdf
2. World Health Organization (2011 b). WHO List of rejected drugs from the list of Essential Medicines. WHO: Geneva. Retrieved 5 June 2012 from http://www.who.int/selection_medicines/committees/REJECTIONS.pdf
3. World Health Organization (2009). The Selection and Use of Essential Medicines. WHO: Geneva. Retrieved 5 June 2012 from http://whqlibdoc.who.int/trs/WHO_TRS_958_eng.pdf
4. Using the needs of WHO to prioritise Cochrane reviews: The case of antipsychotic drugs
5. The Cochrane Collaboration as key player in the struggle for better and more relevant patients- and system-oriented research